143 related articles for article (PubMed ID: 7241892)
1. Protein losses during peritoneal dialysis.
Blumenkrantz MJ; Gahl GM; Kopple JD; Kamdar AV; Jones MR; Kessel M; Coburn JW
Kidney Int; 1981 Apr; 19(4):593-602. PubMed ID: 7241892
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic peritoneal dialysis on thyroid function tests.
Robey C; Shreedhar K; Batuman V
Am J Kidney Dis; 1989 Feb; 13(2):99-103. PubMed ID: 2916576
[TBL] [Abstract][Full Text] [Related]
3. Nutritional effects of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) patients.
Bannister DK; Acchiardo SR; Moore LW; Kraus AP
J Am Diet Assoc; 1987 Jan; 87(1):53-6. PubMed ID: 3794134
[TBL] [Abstract][Full Text] [Related]
4. Plasma and dialysate immunoglobulin G in continuous ambulatory peritoneal dialysis patients: a multicenter study.
De Vecchi AF; Kopple JD; Young GA; Nolph KD; Vonesh EF; Castelnovo C; Dichiro J; Nissenson A; Brownjohn AM; Prowant B
Am J Nephrol; 1990; 10(6):451-6. PubMed ID: 2075902
[TBL] [Abstract][Full Text] [Related]
5. Three years' experience of continuous ambulatory peritoneal dialysis.
Chan MK; Baillod RA; Chuah P; Sweny P; Raftery MJ; Varghese Z; Moorhead JF
Lancet; 1981 Jun; 1(8235):1409-12. PubMed ID: 6113364
[TBL] [Abstract][Full Text] [Related]
6. Reappraisal of protein losses in patients undergoing continuous ambulatory peritoneal dialysis.
Katirtzoglou A; Oreopoulos DG; Husdan H; Leung M; Ogilvie R; Dombros N
Nephron; 1980; 26(5):230-3. PubMed ID: 7422050
[TBL] [Abstract][Full Text] [Related]
7. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.
Aloni Y; Shany S; Chaimovitz C
Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753
[TBL] [Abstract][Full Text] [Related]
8. Losses of 1,25- and 24,25-dihydroxycholecalciferol in the peritoneal fluid of patients treated with continuous ambulatory peritoneal dialysis.
Shany S; Rapoport J; Goligorsky M; Yankowitz N; Zuili I; Chaimovitz C
Nephron; 1984; 36(2):111-3. PubMed ID: 6607420
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of peritoneal clearances in patients undergoing continuous ambulatory peritoneal dialysis.
Rubin J; Nolph K; Arfania D; Brown P; Prowant B
Kidney Int; 1979 Nov; 16(5):619-23. PubMed ID: 548605
[TBL] [Abstract][Full Text] [Related]
10. Acute sterile peritonitis.
Alpert BE; Folkert VW; Longnecker RE; Sherman RA
Nephron; 1982; 30(2):187-9. PubMed ID: 7099327
[TBL] [Abstract][Full Text] [Related]
11. Continuous ambulatory peritoneal dialysis.
Popovich RP; Moncrief JW; Nolph KD; Ghods AJ; Twardowski ZJ; Pyle WK
Ann Intern Med; 1978 Apr; 88(4):449-56. PubMed ID: 637423
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.
Madden MA; Zimmerman SW; Simpson DP
Clin Nephrol; 1981 Dec; 16(6):293-9. PubMed ID: 6797767
[TBL] [Abstract][Full Text] [Related]
13. Serum CA-125 level in end-stage renal disease patients maintained on chronic peritoneal dialysis or hemodialysis: the effect of continuous presence of peritoneal fluid, peritonitis, and peritoneal catheter implantation.
Bastani B; Chu N
Am J Nephrol; 1995; 15(6):468-72. PubMed ID: 8546167
[TBL] [Abstract][Full Text] [Related]
14. Newer modifications of peritoneal dialysis: options in the treatment of patients with renal failure.
Price CG; Suki WN
Am J Nephrol; 1981; 1(2):97-104. PubMed ID: 7349048
[TBL] [Abstract][Full Text] [Related]
15. [Our experience with the diagnosis of peritonitis complicating a long-term program of peritoneal dialysis].
Wańkowicz Z; Panasiuk E; Pietrzak B; Smoszna J; Witman D
Pol Arch Med Wewn; 1992 Jun; 87(6):386-92. PubMed ID: 1408997
[TBL] [Abstract][Full Text] [Related]
16. Plasma amino acid levels and amino acid losses during continuous ambulatory peritoneal dialysis.
Kopple JD; Blumenkrantz MJ; Jones MR; Moran JK; Coburn JW
Am J Clin Nutr; 1982 Sep; 36(3):395-402. PubMed ID: 7113946
[TBL] [Abstract][Full Text] [Related]
17. Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.
Thomson NM; Walker RG; Whiteside G; Scott DF; Atkins RC
Proc Eur Dial Transplant Assoc; 1979; 16():171-7. PubMed ID: 548978
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of albumin loss during peritoneal dialysis in man.
Bianchi R; Mariani G; Pilo A; Carmassi F
Eur J Clin Invest; 1975 Sep; 5(5):409-13. PubMed ID: 1183476
[TBL] [Abstract][Full Text] [Related]
19. Peritonitis - does peritoneal dialysis modality make a difference?
Piraino B; Sheth H
Blood Purif; 2010; 29(2):145-9. PubMed ID: 20093820
[TBL] [Abstract][Full Text] [Related]
20. Flucytosine-miconazole treatment of Candida peritonitis. Its use during continuous ambulatory peritoneal dialysis.
Lempert KD; Jones JM
Arch Intern Med; 1982 Mar; 142(3):577-8. PubMed ID: 7065793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
